Reuters: Health
Drug developer Neurotrope Inc's shares tumbled nearly 80% on Monday after the company said its experimental treatment for Alzheimer's disease did not meet the main goal of a mid-stage study.
Neurotrope shares crash after Alzheimer's drug fails in trial
Neurotrope shares crash after Alzheimer's drug fails in trial
Reuters: Health
Drug developer Neurotrope Inc's shares tumbled nearly 80% on Monday after the company said its experimental treatment for Alzheimer's disease did not meet the main goal of a mid-stage study.
Reuters: Health
Drug developer Neurotrope Inc's shares tumbled nearly 80% on Monday after the company said its experimental treatment for Alzheimer's disease did not meet the main goal of a mid-stage study.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment